Nalaganje...
Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity
Immuno-oncology (I-O) has required a shift in the established paradigm of toxicity and response assessment in clinical research. The design and interpretation of cancer clinical trials has been primarily driven by conventional toxicity and efficacy patterns observed with chemotherapy and targeted ag...
Shranjeno v:
| izdano v: | Clin Cancer Res |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5735844/ https://ncbi.nlm.nih.gov/pubmed/28864724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-3065 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|